DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo

Pfizer (NYSE: PFE)

company name or ticker
Company Photos
(Click to zoom)

Irish M&A: Not Too Irish And Mostly Inversions

3 Numbers That Will Matter When Pfizer Reports Its Fourth-Quarter Results

These three figures bear a lot of importance when the kingpin of Big Pharma reports its fourth-quarter results on Feb. 2.

Here's What to Know Ahead of Pfizer's (PFE) Earnings Results

4 Out-Of-Favor Large-Cap Blue-Chip Dividend Stocks to Buy Now

Regeneron - A Review: Strong Returns Look Likely For 2016 And Beyond

Large Johnson & Johnson Shareholder Just Revealed 8 Major Concerns

Novartis (NVS) Lags Q4 Earnings & Revenues, Alcon Down

Bristol-Myers Beats on Q4 Earnings, Provides 2016 Guidance

4 Reasons Why Johnson & Johnson Exploded Higher Following Its Q4 Earnings Release

Johnson & Johnson's Q4 results may have been "mixed," but there was no shortage of good news hidden beneath the headline numbers.

Pfizer vs. Merck -- Which Is the Better Dividend Stock Right Now?

See More Articles...